recurrent mantle cell lymphoma
Showing NaN - NaN of 6
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma Trial in
Recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +13 more
- Polatuzumab Vedotin
- +3 more
-
Scottsdale, Arizona
- +11 more
Aug 23, 2022
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +45 more
- anti-endosialin/TEM1 monoclonal antibody MORAb-004
- +2 more
-
Birmingham, Alabama
- +19 more
Jan 7, 2016
Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma Trial in New
Completed
- Recurrent Grade 1 Follicular Lymphoma
- +3 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Nov 2, 2015
Adult B Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Cutaneous B-Cell Non-Hodgkin Lymphoma Trial in United States
Terminated
- Adult B Acute Lymphoblastic Leukemia
- +28 more
- Ibrutinib
- +2 more
-
Los Angeles, California
- +6 more
Aug 18, 2015
Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +50 more
- Akt inhibitor MK2206
- +2 more
-
Birmingham, Alabama
- +24 more
Apr 28, 2014
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +84 more
- sunitinib malate
- +2 more
-
Los Angeles, California
- +10 more
Mar 14, 2014